Novartis Korea to reach the final agreement on Glivec's insurance price

Published: 2002-07-02 07:00:00

Updated: 2002-07-02 07:00:00

Novartis Korea said it will endeavor to reach a final pricing agreement of a novel anticancer therapy 'Glivec' with the Ministry of Health and Welfare (MOHW) based on the domestic insurance calculation criteria, in line with the delayed decision on the ceiling price of Glivec in the National Health Insurance Policy Deliberation Council under the MOHW to have held on June 25.

Novartis Korea s...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.